Respiratory distress – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Sat, 20 Jun 2026 04:04:01 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Respiratory distress – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on How Nitrous Oxide and Oxygen Affect Lung Health in Children with Respiratory Disorders https://clinicaltrials.eu/trial/study-on-how-nitrous-oxide-and-oxygen-affect-lung-health-in-children-with-respiratory-disorders/ Wed, 29 Apr 2026 15:04:00 +0000 https://clinicaltrials.eu/trial/study-on-how-nitrous-oxide-and-oxygen-affect-lung-health-in-children-with-respiratory-disorders/ This clinical trial is focused on studying the effects of a treatment called KALINOX 50%/50%, which is a medicinal gas made up of nitrous oxide and oxygen. The study is specifically looking at children who have respiratory disorders, such as severe asthma or suspected lung infections, and need to have samples taken from their airways. The main goal is to see if using this gas changes the types of bacteria found in the lungs of these children.

During the study, children will inhale the gas, and samples will be collected from their airways to analyze the bacteria present. The study will also look at how well children tolerate the gas and how it affects the quality of the samples collected. Researchers will use different methods to assess the variety of bacteria in the lungs and will also monitor any side effects that might occur.

The trial aims to provide a better understanding of how nitrous oxide affects lung bacteria in children with respiratory issues. This information could help improve treatments for children with conditions like severe asthma or lung infections. The study is expected to continue until December 2026.

]]> Study on the Effect of Rocuronium Bromide, Sugammadex, and Suxamethonium Chloride for Adults with Respiratory Distress Requiring Emergency Tracheal Intubation https://clinicaltrials.eu/trial/study-on-the-effect-of-rocuronium-bromide-sugammadex-and-suxamethonium-chloride-for-adults-with-respiratory-distress-requiring-emergency-tracheal-intubation/ Wed, 29 Apr 2026 14:59:34 +0000 https://clinicaltrials.eu/trial/study-on-the-effect-of-rocuronium-bromide-sugammadex-and-suxamethonium-chloride-for-adults-with-respiratory-distress-requiring-emergency-tracheal-intubation/ This clinical trial is focused on improving the process of emergency tracheal intubation, which is a procedure used to help patients breathe when they are experiencing severe breathing problems, known as respiratory distress. The study will use a combination of medications and techniques to see if they can reduce complications that might occur after the procedure. The medications involved in this study include Rocuronium, Sugammadex, and Suxamethonium. These are used to help relax the muscles during intubation, making the process smoother and potentially safer.

The purpose of the study is to evaluate whether this new strategy can decrease the number of complications that happen shortly after intubation. Participants in the study will receive either the new combination of treatments or the usual care. The study will observe the effects of these treatments on patients who need emergency intubation outside of a hospital setting. The trial will monitor the patients for any severe complications, such as low blood pressure, low oxygen levels, or other issues that might arise during the first hour after intubation.

Throughout the study, researchers will also look at how difficult the intubation process is, how long it takes to provide care outside the hospital, and the amount of medication needed after intubation. The study will follow patients until they are admitted to the hospital and will check their health status up to 28 days later. This research aims to find better ways to perform emergency intubations and improve patient outcomes.

]]>